×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| IND-SWIFT LTD. | 1227.83 | -54.98 | 1201.34 | -1.02 | 82.2 | 1.28 |
| BIOFIL CHEMICALS & PHARMACEUTI | 142.18 | 1.65 | 141.95 | 0.10 | 82 | 137.0 |
| WELCURE DRUGS & PHARMACEUTICAL | 88.38 | 4.15 | 88.38 | 0.04 | 81.9 | 43.6 |
Ind-Swift Ltd., with Security Code 524652, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.6 | 103.8 | 106.5 | 105.8 | 148.5 | 115.9 | 102.5 | 135.2 | 113.8 | 136.3 |
| Expenses | 89.5 | 92.9 | 88.7 | 97.9 | 130.1 | 104.8 | 98.1 | 120.7 | 110.6 | 121.9 |
| Operating Profit | 5.1 | 10.9 | 17.9 | 8.0 | 18.4 | 11.1 | 4.5 | 14.5 | 3.2 | 14.4 |
| OPM % | 5.41% | 10.52% | 16.79% | 7.51% | 12.39% | 9.61% | 4.38% | 10.71% | 2.83% | 10.57% |
| Other Income | 1.5 | 1.0 | 3.2 | 66.9 | 5.6 | 3.2 | 2.6 | 46.6 | 39.9 | 4.6 |
| Interest | 15.1 | 15.4 | 14.8 | 14.5 | 14.9 | 18.3 | 15.3 | 14.4 | 9.5 | 9.5 |
| Depreciation | 7.0 | 7.1 | 7.3 | 7.2 | 6.7 | 6.7 | 6.8 | 6.9 | 5.4 | 5.4 |
| Profit before tax | -15.4 | -10.6 | -1.0 | -7.5 | 2.4 | -10.7 | -15.0 | 39.8 | 28.2 | 4.1 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -15.4 | -10.6 | -1.0 | 53.1 | 2.4 | -10.7 | -15.0 | 37.5 | 28.2 | 4.1 |
| EPS in Rs | -2.85 | -1.96 | -0.19 | 9.8 | 0.44 | -1.98 | -2.76 | 6.93 | 5.21 | 0.76 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 103.8 | 106.6 | 105.9 | 148.5 | 115.9 | 102.6 | 135.2 | 113.9 | 136.3 | 120.1 |
| Expenses | 92.9 | 88.7 | 97.9 | 130.1 | 104.8 | 98.1 | 120.8 | 110.6 | 121.9 | 112.8 |
| Operating Profit | 10.9 | 17.9 | 7.9 | 18.4 | 11.1 | 4.5 | 14.5 | 3.2 | 14.4 | 7.3 |
| OPM % | 10.5% | 16.8% | 7.5% | 12.4% | 9.6% | 4.4% | 10.7% | 2.8% | 10.6% | 6.1% |
| Other Income | 1.0 | 3.2 | 66.9 | 5.6 | 3.2 | 2.6 | 46.6 | 39.9 | 4.6 | 2.6 |
| Interest | 15.4 | 14.8 | 14.5 | 14.9 | 18.3 | 15.3 | 14.4 | 9.5 | 9.5 | 9.9 |
| Depreciation | 7.1 | 7.3 | 7.2 | 6.7 | 6.7 | 6.8 | 6.9 | 5.4 | 5.4 | 5.6 |
| Profit before tax | -10.6 | -1.0 | -7.5 | 2.4 | -10.7 | -15.0 | 39.8 | 28.2 | 4.1 | -5.5 |
| Tax % | -0% | -0% | 0% | 0% | -0% | -0% | 0% | 0% | 0% | -0% |
| Net Profit | -10.6 | -1.0 | 53.1 | 2.4 | -10.7 | -15.0 | 37.5 | 28.2 | 4.1 | -5.5 |
| EPS in Rs | -1 | 0 | 9 | 0 | -1 | -2 | 6 | 5 | 0 | -1 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -7% |
| 3 Years: | 5% |
| TTM: | 309% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 41% |
| 3 Years: | 10% |
| 1 Year: | -15% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 309% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 41% |
| 3 Years: | 10% |
| 1 Year: | -15% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|